Tawfik Essam A, Tawfik Abdulkader F, Alajmi Areej M, Badr Moutaz Y, Al-Jedai Ahmed, Almozain Nada H, Bukhary Haitham A, Halwani Abdulrahman A, Al Awadh Saeed A, Alshamsan Aws, Babhair Salim, Almalik Abdulaziz M
National Center of Biotechnology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
Drug Dimension Company, Riyadh, Saudi Arabia.
Saudi Pharm J. 2022 Jan;30(1):28-38. doi: 10.1016/j.jsps.2021.12.002. Epub 2021 Dec 20.
Local production of pharmaceuticals plays a vital role in maintaining resilience of national healthcare systems, especially when it comes to facilitating access to needed medicines and decreasing exposure to imports and international supply chains. Pharma is a research-intensive industry and the systemic lack of governance and support to R&D activities in this sector, among other host of related issues such as unsupportive regulatory regimes and human resources capacity limitations, is one of the major impediments to the diversifying of locally produced pharmaceuticals portfolio. In this review, an overview of the current pharmaceutical production system in Saudi Arabia, its major challenges, and proposed remedies to address them will be highlighted.
药品的本地生产在维持国家医疗保健系统的韧性方面发挥着至关重要的作用，特别是在促进获取所需药品以及减少对进口和国际供应链的依赖方面。制药是一个研究密集型产业，该部门研发活动系统性地缺乏治理和支持，以及其他一系列相关问题，如不支持的监管制度和人力资源能力限制，是本地生产药品组合多样化的主要障碍之一。在本综述中，将重点介绍沙特阿拉伯目前的药品生产系统、其主要挑战以及为解决这些挑战而提出的补救措施。
